GSK Vaccines Institute For Global Health S.r.l.
2 clinical trials · Sponsor
◉ Watch GSK Vaccines Institute For Global Health S.r.l.
| Record | Firm | Date |
|---|---|---|
| Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults (NCT02034500) | GSK Vaccines Institute For Global Health S.r.l. | 2014-03-01 |
| A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults. (NCT02017899) | GSK Vaccines Institute For Global Health S.r.l. | 2014-02-01 |
Track GSK Vaccines Institute For Global Health S.r.l. automatically
Every clearance here is in the API, with alerts when new ones post.